Huiyihuiying launches new AI Full Cycle Health Management Cloud Platform based on AI 2.0 tech
November 21, 2018 / Dean Koh
Huiyihuiying, a Chinese medical imaging artificial intelligence company, yesterday announced the launch of their new AI Full Cycle Health Management Cloud Platform, which consists of two separate platforms for different health concerns: the Breast Cancer AI Full Cycle Health Management Platform and the AORTIST 2.0 Aorta AI Cloud Platform. The platforms are based on AI 2.0 technology and were introduced at Chinese Congress of Radiology 2018 (CCR 2018) in the National Congress Center on November 8, 2018. The Breast Cancer AI Full Cycle Health Management Platform is committed to the whole cycle of breast cancer diagnosis and treatment, from breast molybdenum target screening to nuclear magnetic diagnosis to pathological diagnosis. The ARTIST 2.0 Aortic AI Cloud platform is to provide a process for the identification of breaks, choosing cardiac stents, and the prognosis of follow-up treatment.